PDI News
Most Popular PDI Story
C&L: Tedford resigns early from Patheon
Contract drug manufacturer Patheon has announced that Robert Tedford has turned in his resignation 10 months ahead of schedule. Patheon chairman Peter Green, president and CEO Nick DiPietro, and CFO and executive vice-president Douglas Ludwig have formed the "office of the chief …
Read more...Latest Headlines
- September 25, 2006
- May 16, 2006
- May 9, 2006
- February 27, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
